CN104225043A - Oral medicine preparation for treating chronic cholecystitis - Google Patents
Oral medicine preparation for treating chronic cholecystitis Download PDFInfo
- Publication number
- CN104225043A CN104225043A CN201410508042.6A CN201410508042A CN104225043A CN 104225043 A CN104225043 A CN 104225043A CN 201410508042 A CN201410508042 A CN 201410508042A CN 104225043 A CN104225043 A CN 104225043A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- medicine preparation
- chronic cholecystitis
- oral medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral medicine preparation for treating chronic cholecystitis. The oral medicine preparation is prepared from the following bulk drugs in parts by weight: 20-30 parts of angelica dahurica, 20-30 parts of cassia twigs, 5-15 parts of buthus martensi karsch scorpion, 5-15 parts of semen oroxyli, 10-20 parts of common selfheal fruit-spikes, 10-20 parts of climbing groundsel herbs, 5-15 parts of longtube ground ivy herbs, 20-30 parts of forsythia suspensa, 20-30 parts of coastal glehnia roots, 10-20 parts of lancea tibetica, 5-15 parts of roots of Indian kalimeris herbs, 10-15 parts of immature orange fruits, and 2-5 parts of musk. During treatment, the oral medicine preparation is taken orally twice a day, and 2-4 grams of the oral medicine preparation is taken each time. In one course of treatment, a patient takes the oral medicine preparation for 15 days continuously. For a patient with a slight state of the chronic cholecystitis, after the patient takes the oral medicine preparation for 2-3 courses of treatment, the chronic cholecystitis is healed; and for a patient with a serious state of the chronic cholecystitis, after the patient takes the oral medicine preparation for 3-5 courses of treatment, the chronic cholecystitis is healed. The oral medicine preparation for treating the chronic cholecystitis mainly treats the chronic cholecystitis, and through the application of the oral medicine preparation for many years, the effective rate reaches more than 95%. The oral medicine preparation has the advantages of stable therapeutic effect, significant effect, no toxic or side effects, low cost and the like.
Description
Technical field
The present invention relates to a kind of oral drug preparation for the treatment of chronic cholecystitis.
Background technology
Chronic disease mainly refers to take cardiovascular and cerebrovascular disease (hypertension, coronary heart disease, apoplexy etc.), diabetes, malignant tumor, chronic obstructive disease of lung (chronic tracheitis, emphysema etc.), psychological problem and psychosis etc. as one group of disease of representative, has that the course of disease is long, the cause of disease is complicated, Health cost and a feature such as social danger is serious.The control of current chronic disease has become one of the emphasis research topic of Ministry of Public Health, scientific research institution, hospital, can drop into substantial contribution and manpower for studying the prevention and cure of chronic disease in the coming years.
Cholecystitis is subject to antibacterial, calculus, the invasion and attack of chemokines and the inflammation that occurs by biliary system, has acute and chronic point clinically, acute cholecystitis with heating, bottom right rib pain, vomiting, leukocytosis etc. for main manifestations; Chronic cholecystitis can exist with cholelithiasis simultaneously, can, because of caused by cholestasis, be also often the sequela of acute cholecystitis, clinically normal with discomfort or lasting dull pain under right rib for main manifestations.Cholelithiasis often occurs together cholecystitis.Current treatment primary disease many employings anti-inflammatory and choleretic class medicine, as XIAOYAN LIDAN PIAN, disappear bladder, also symptom not alleviation person is had sometimes to add digestion class medicine JIANWEI XIAOSHI PIAN etc., also the oral administration and externally used medicine sharer of application is had, but effect is all undesirable, there is curative effect instability, the course for the treatment of is long, side effect is more, expensive, the weak point such as slowly of producing effects.
Summary of the invention
For above-mentioned prior art, the invention provides a kind of oral drug preparation for the treatment of chronic cholecystitis, its therapeutic effect is good, with low cost, has no side effect.
The present invention is achieved by the following technical solutions:
Treat an oral drug preparation for chronic cholecystitis, be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 20 ~ 30 parts, Ramulus Cinnamomi 20 ~ 30 parts, Scorpio 5 ~ 15 parts, Semen Oroxyli 5 ~ 15 parts, Spica Prunellae 10 ~ 20 parts, Herba Senecionis Scandentis 10 ~ 20 parts, Herba Glechomae 5 ~ 15 parts, Fructus Forsythiae 20 ~ 30 parts, Radix Glehniae 20 ~ 30 parts, Fructus Lanceae tibeticae 10 ~ 20 parts, root of Indian kalimeris herb 5 ~ 15 parts, Fructus Aurantii Immaturus 10 ~ 15 parts, 2 ~ 5 parts, Moschus.
Preferably, be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 25 parts, Ramulus Cinnamomi 25 parts, Scorpio 10 parts, Semen Oroxyli 10 parts, Spica Prunellae 15 parts, Herba Senecionis Scandentis 15 parts, Herba Glechomae 10 parts, Fructus Forsythiae 25 parts, Radix Glehniae 25 parts, Fructus Lanceae tibeticae 15 parts, root of Indian kalimeris herb 10 parts, Fructus Aurantii Immaturus 13 parts, 3 parts, Moschus.
The preparation method of the oral drug preparation of described treatment chronic cholecystitis is: get each crude drug, mixing, pulverizes, and crosses 300 mesh sieves, loads 2# capsule, to obtain final product.
During treatment, oral, every day twice, each 2 ~ 4 grams.It within 15 days, is a course for the treatment of.State of an illness the lighter cures 2 ~ 3 courses for the treatment of, and state of an illness severe one is cured 3 ~ 5 courses for the treatment of.
The oral drug preparation for the treatment of chronic cholecystitis of the present invention, cures mainly chronic cholecystitis, and through applying for many years, effective percentage more than 95%, stable curative effect, Be very effective, has no side effect, with low cost, is a kind of rare good medicine.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1 prepares the oral drug preparation for the treatment of chronic cholecystitis
Formula is: the Radix Angelicae Dahuricae 25 grams, Ramulus Cinnamomi 25 grams, Scorpio 10 grams, Semen Oroxyli 10 grams, Spica Prunellae 15 grams, Herba Senecionis Scandentis 15 grams, Herba Glechomae 10 grams, Fructus Forsythiae 25 grams, Radix Glehniae 25 grams, Fructus Lanceae tibeticae 15 grams, root of Indian kalimeris herb 10 grams, Fructus Aurantii Immaturus 13 grams, 3 grams, Moschus.
Preparation method is: get each crude drug, mixing, pulverizes, and crosses 300 mesh sieves, loads 2# capsule, to obtain final product.
During treatment, oral, every day twice, each 3 grams (in drug powders).It within 15 days, is a course for the treatment of.
Embodiment 2 prepares the oral drug preparation for the treatment of chronic cholecystitis
Formula is: the Radix Angelicae Dahuricae 22 grams, Ramulus Cinnamomi 28 grams, Scorpio 8 grams, Semen Oroxyli 13 grams, Spica Prunellae 12 grams, Herba Senecionis Scandentis 18 grams, Herba Glechomae 8 grams, Fructus Forsythiae 28 grams, Radix Glehniae 22 grams, Fructus Lanceae tibeticae 18 grams, root of Indian kalimeris herb 8 grams, Fructus Aurantii Immaturus 14 grams, 3 grams, Moschus.
Preparation method is: get each crude drug, mixing, pulverizes, and crosses 300 mesh sieves, incapsulates and make capsule, to obtain final product.
Therapeutic modality is with embodiment 1.
Embodiment 3 prepares the oral drug preparation for the treatment of chronic cholecystitis
Formula is: the Radix Angelicae Dahuricae 27 grams, Ramulus Cinnamomi 23 grams, Scorpio 12 grams, Semen Oroxyli 7 grams, Spica Prunellae 17 grams, Herba Senecionis Scandentis 13 grams, Herba Glechomae 14 grams, Fructus Forsythiae 21 grams, Radix Glehniae 26 grams, Fructus Lanceae tibeticae 14 grams, root of Indian kalimeris herb 11 grams, Fructus Aurantii Immaturus 14 grams, 4 grams, Moschus.
Preparation method and therapeutic modality are with embodiment 1.
Embodiment 4 prepares the oral drug preparation for the treatment of chronic cholecystitis
Formula is: the Radix Angelicae Dahuricae 20 grams, Ramulus Cinnamomi 20 grams, Scorpio 15 grams, Semen Oroxyli 15 grams, Spica Prunellae 10 grams, Herba Senecionis Scandentis 10 grams, Herba Glechomae 15 grams, Fructus Forsythiae 30 grams, Radix Glehniae 20 grams, Fructus Lanceae tibeticae 10 grams, root of Indian kalimeris herb 15 grams, Fructus Aurantii Immaturus 15 grams, 2 grams, Moschus.
Preparation method and therapeutic modality are with embodiment 1.
Embodiment 5 prepares the oral drug preparation for the treatment of chronic cholecystitis
Formula is: the Radix Angelicae Dahuricae 30 grams, Ramulus Cinnamomi 30 grams, Scorpio 5 grams, Semen Oroxyli 5 grams, Spica Prunellae 20 grams, Herba Senecionis Scandentis 20 grams, Herba Glechomae 5 grams, Fructus Forsythiae 20 grams, Radix Glehniae 30 grams, Fructus Lanceae tibeticae 20 grams, root of Indian kalimeris herb 5 grams, Fructus Aurantii Immaturus 10 grams, 5 grams, Moschus.
Preparation method and therapeutic modality are with embodiment 1.
Clinical statistics data:
Basic document: selected 178 routine patients are all outpatient service or inpatient, wherein between 28 ~ 62 years old age, average 45 years old; The most elder of the course of disease 8 years, the shortest person 6 months.All suffers from chronic cholecystitis.
Diagnostic criteria: chronic cholecystitis does ultrasonic examination, gallbladder wall > 0.4cm, inner wall coarse.Clinical symptoms has epigastrium distending pain, RHC dull pain, dull pain or burns sample pain, and ache in radioactivity back simultaneously.
Therapeutic modality: the medicine and the therapeutic modality treatment that adopt embodiment 1.Observe the curative effect after four courses for the treatment of.
The standard of curative effect evaluation:
Cure: ultrasonic display gallbladder wall < 0.3cm, inner wall smooth, clinical symptoms disappears completely, does not recur after following up a case by regular visits to 1 year.
Effective: ultrasonic display gallbladder wall < 0.3cm, gallbladder wall owes smooth, and clinical symptoms obviously alleviates.
Invalid: ultrasonic display gallbladder wall > 0.4cm, inner wall coarse, clinical symptoms still exists or seriously.
Therapeutic outcome: 204 routine patients, cures 176 examples, effective 19 examples, no effect 9, cure rate 86.3%, total effective rate 95.6%.
Claims (5)
1. treat an oral drug preparation for chronic cholecystitis, it is characterized in that: be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 20 ~ 30 parts, Ramulus Cinnamomi 20 ~ 30 parts, Scorpio 5 ~ 15 parts, Semen Oroxyli 5 ~ 15 parts, Spica Prunellae 10 ~ 20 parts, Herba Senecionis Scandentis 10 ~ 20 parts, Herba Glechomae 5 ~ 15 parts, Fructus Forsythiae 20 ~ 30 parts, Radix Glehniae 20 ~ 30 parts, Fructus Lanceae tibeticae 10 ~ 20 parts, root of Indian kalimeris herb 5 ~ 15 parts, Fructus Aurantii Immaturus 10 ~ 15 parts, 2 ~ 5 parts, Moschus.
2. the medicine for the treatment of chronic cholecystitis according to claim 1, is characterized in that: be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 25 parts, Ramulus Cinnamomi 25 parts, Scorpio 10 parts, Semen Oroxyli 10 parts, Spica Prunellae 15 parts, Herba Senecionis Scandentis 15 parts, Herba Glechomae 10 parts, Fructus Forsythiae 25 parts, Radix Glehniae 25 parts, Fructus Lanceae tibeticae 15 parts, root of Indian kalimeris herb 10 parts, Fructus Aurantii Immaturus 13 parts, 3 parts, Moschus.
3. the medicine for the treatment of chronic cholecystitis according to claim 1, is characterized in that: be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 22 grams, Ramulus Cinnamomi 28 grams, Scorpio 8 grams, Semen Oroxyli 13 grams, Spica Prunellae 12 grams, Herba Senecionis Scandentis 18 grams, Herba Glechomae 8 grams, Fructus Forsythiae 28 grams, Radix Glehniae 22 grams, Fructus Lanceae tibeticae 18 grams, root of Indian kalimeris herb 8 grams, Fructus Aurantii Immaturus 14 grams, 3 grams, Moschus.
4. the medicine for the treatment of chronic cholecystitis according to claim 1, is characterized in that: be made up of the crude drug of following weight portion: the Radix Angelicae Dahuricae 27 grams, Ramulus Cinnamomi 23 grams, Scorpio 12 grams, Semen Oroxyli 7 grams, Spica Prunellae 17 grams, Herba Senecionis Scandentis 13 grams, Herba Glechomae 14 grams, Fructus Forsythiae 21 grams, Radix Glehniae 26 grams, Fructus Lanceae tibeticae 14 grams, root of Indian kalimeris herb 11 grams, Fructus Aurantii Immaturus 14 grams, 4 grams, Moschus.
5. the preparation method of the oral drugs of the treatment chronic cholecystitis described in Claims 1 to 4, is characterized in that: get each crude drug, mixing, pulverizes, and crosses 300 mesh sieves, incapsulates, to obtain final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410508042.6A CN104225043A (en) | 2014-09-28 | 2014-09-28 | Oral medicine preparation for treating chronic cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410508042.6A CN104225043A (en) | 2014-09-28 | 2014-09-28 | Oral medicine preparation for treating chronic cholecystitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104225043A true CN104225043A (en) | 2014-12-24 |
Family
ID=52214519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410508042.6A Pending CN104225043A (en) | 2014-09-28 | 2014-09-28 | Oral medicine preparation for treating chronic cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104225043A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413688A (en) * | 2002-11-13 | 2003-04-30 | 贵州省安顺制药厂 | Medicine for treating cholecystopathy |
| CN103405738A (en) * | 2013-08-22 | 2013-11-27 | 张素平 | Pharmaceutical composition for treating chronic cholecystitis |
-
2014
- 2014-09-28 CN CN201410508042.6A patent/CN104225043A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413688A (en) * | 2002-11-13 | 2003-04-30 | 贵州省安顺制药厂 | Medicine for treating cholecystopathy |
| CN103405738A (en) * | 2013-08-22 | 2013-11-27 | 张素平 | Pharmaceutical composition for treating chronic cholecystitis |
Non-Patent Citations (4)
| Title |
|---|
| 中华中医药学会脾胃病分会: "胆囊炎中医诊疗规范专家共识意见", 《北京中医药》 * |
| 吕兰薰: "利胆与溶石排石中药的研究动态", 《陕西中医学院学报》 * |
| 朱成栋: "中医药治疗慢性胆囊炎进展", 《现代中西医结合杂志》 * |
| 王文正等: "胆囊炎、胆石症辨证治疗点滴", 《山东医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102247541A (en) | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma | |
| CN104225043A (en) | Oral medicine preparation for treating chronic cholecystitis | |
| CN101143199A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN102670736A (en) | External ointment for treating various skin diseases | |
| CN103239689B (en) | Chinese medicine preparation for treating chronic cholecystitis | |
| CN103169927B (en) | Traditional Chinese medicine preparation for treating chronic cholecystitis | |
| CN101204444B (en) | Cataplasm for amygdalitis | |
| CN105213519A (en) | A kind of medicine and preparation method thereof for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny | |
| CN103735931B (en) | A kind of Chinese medicine preparation for the treatment of chronic cholecystitis | |
| CN103041192A (en) | Bedsore paste | |
| CN102626441B (en) | Antipyrotic powder for external use | |
| CN103007004B (en) | One treats tetanic Chinese medicine decoction and preparation method thereof | |
| CN101134098A (en) | Traditional Chinese medicine for treating biliary ascariasis | |
| CN104706992A (en) | Lung astringing and cough relieving traditional Chinese medicine composition | |
| CN104958559A (en) | Medicament for treating sciatica | |
| CN104547374A (en) | Combinatorial medicament for promoting healing of bone | |
| Bhide et al. | USE OF AYURVEDIC MEDICINES TO TREAT VARIOUS CHRONIC DISEASES | |
| CN101199695B (en) | Powders medicament for treating sinusitis | |
| CN1463726A (en) | Externally applied traditional Chinese medicine for treating cancer and ache | |
| CN104922291A (en) | Drug for treatment of coronary heart disease | |
| CN101134061A (en) | Traditional Chinese medicine for treating chronic headache | |
| CN104173779A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN1276772C (en) | Externally-applied medicine for treating hyperosteogeny and its preparation | |
| CN103845655A (en) | Chinese medicinal composition for treating chronic cholecystitis | |
| CN101683393A (en) | Dandelion formulation for treating urinary infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |
|
| RJ01 | Rejection of invention patent application after publication |